| RS2131444517 |
SETX
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS2131450364 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131450525 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2131451053 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131451091 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131452462 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131453888 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131453910 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS2131454006 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131454461 |
ZNF462
|
Health Risk |
Likely pathogenic |
Weiss-Kruszka syndrome, Weiss-Kruszka syndrome |
| RS2131454649 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131454682 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131454714 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131454847 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131455014 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131455281 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131456686 |
ABCA2
|
Health Risk |
Likely pathogenic |
— |
| RS2131458386 |
CUBN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS2131458620 |
CUBN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS2131461009 |
SETX
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS2131462357 |
STXBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic ataxia, Early-infantile DEE |
| RS2131462561 |
GABBR2
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS2131462794 |
ZNF462
|
Health Risk |
Pathogenic |
— |
| RS2131462829 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131462929 |
STXBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2131463306 |
SETX
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 4, Amyotrophic lateral sclerosis type 4 |
| RS2131463325 |
SETX
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 4, Amyotrophic lateral sclerosis type 4 |
| RS2131463657 |
SETX
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 4, Amyotrophic lateral sclerosis type 4 |
| RS2131465180 |
ZNF462
|
Health Risk |
Pathogenic |
Weiss-Kruszka syndrome, Weiss-Kruszka syndrome |
| RS2131469253 |
STXBP1
|
Health Risk |
Pathogenic |
— |
| RS2131469592 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131471759 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS2131472407 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131472700 |
STXBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2131472708 |
STXBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2131472862 |
FBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS2131473052 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131473842 |
ZNF462
|
Health Risk |
Pathogenic |
— |
| RS2131480409 |
IFT74
|
Health Risk |
Pathogenic |
Joubert syndrome 40, Joubert syndrome 40 |
| RS2131481227 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131481245 |
STXBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2131481488 |
STXBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131481623 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131481685 |
STXBP1
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131481907 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131482893 |
GATA3
|
Health Risk |
Likely pathogenic |
Hearing impairment, Hearing impairment |
| RS2131485407 |
SHOC1
|
Health Risk |
Pathogenic |
Non-obstructive azoospermia, Non-obstructive azoospermia |
| RS2131486442 |
FBP1
|
Health Risk |
Pathogenic |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS2131488650 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS2131488754 |
OPTN
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 12, Glaucoma 1 |
| RS2131488795 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131488835 |
ZNF462
|
Health Risk |
Pathogenic |
Weiss-Kruszka syndrome, Weiss-Kruszka syndrome |
| RS2131488863 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS2131488897 |
STXBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2131488944 |
OPTN
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 12, Amyotrophic lateral sclerosis type 12 |
| RS2131488953 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS2131488963 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131489143 |
STXBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2131489331 |
GATA3
|
Health Risk |
Pathogenic |
— |
| RS2131491388 |
GATA3
|
Health Risk |
Pathogenic |
— |
| RS2131491404 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS2131493453 |
GDAP1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease type 4A |
| RS2131493519 |
GDAP1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease type 4A |
| RS2131497207 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131497242 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131497300 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131497737 |
KCNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
KCNT1-related channelopathy, Developmental and epileptic encephalopathy |
| RS2131499119 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131499515 |
BICD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinal muscular atrophy, lower extremity-predominant |
| RS2131500277 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS2131500523 |
GATA3
|
Health Risk |
Pathogenic |
— |
| RS2131500548 |
GATA3
|
Health Risk |
Likely pathogenic |
Hypoparathyroidism, deafness |
| RS2131500576 |
BICD2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2131500581 |
GATA3
|
Health Risk |
Likely pathogenic |
— |
| RS2131500629 |
GATA3
|
Health Risk |
Pathogenic |
— |
| RS2131500836 |
GATA3
|
Health Risk |
Likely pathogenic |
Hypoparathyroidism, deafness |
| RS2131501072 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131501111 |
GATA3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Neoplasm |
| RS2131501118 |
GATA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypoparathyroidism, deafness |
| RS2131501178 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS2131501460 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131501481 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131504104 |
BICD2
|
Health Risk |
Likely pathogenic |
Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures, Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures |
| RS2131504115 |
BICD2
|
Health Risk |
Likely pathogenic |
— |
| RS2131505194 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131505712 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131506184 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2131507600 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131508948 |
HACD1
|
Health Risk |
Likely pathogenic |
— |
| RS2131509216 |
FBP1
|
Health Risk |
Pathogenic |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS2131510168 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131510237 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131510638 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131510675 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131511337 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131511467 |
KRIT1
|
Health Risk |
Pathogenic |
— |
| RS2131511487 |
GATA3
|
Health Risk |
Likely pathogenic |
— |
| RS2131511647 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS2131511667 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131511714 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |